All the stats on Cancer, all in one place.
Between August 2004 and July 2014, the FDA approved:
o 6 new anticancer therapeutics
o 5 new uses for previously approved anticancer therape [Permalink]
A 1 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and incr [Permalink]
Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicine [Permalink]
Subscribe to our RSS Feed for all of the latest information on The Silver Book. To narrow your feed, subscribe from the page with the specific facts you're interested in.